Form 4: United Therapeutics Director Tommy G. Thompson Executes Share Tracking Award, Adjusts Holdings
SEC Form 4 Filing
Director Tommy G. Thompson exercised share tracking awards and adjusted his holdings in United Therapeutics Corp. on March 1, 2024.
Summary
- On March 1, 2024, Tommy G. Thompson, a director of United Therapeutics Corp, executed a transaction involving share tracking awards.
- He exercised 2,000 share tracking awards at a price of $88.03.
- These awards are non-dilutive cash-settled stock appreciation rights.
- Following the transaction, Thompson directly owns 10,480 shares of common stock.
- He also indirectly owns 5,800 shares through a Family LLC and 8,200 shares through a Trust.
- The share tracking awards were exercisable from June 26, 2015, and expire on June 26, 2024.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing insider transactions, which carries a neutral sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company directors.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding the director's holdings and trading activity.
Key Dates
| Date | Description |
|---|---|
| 06/26/2015 | Date share tracking awards became exercisable |
| 03/01/2024 | Date of transaction (exercise of share tracking awards) |
| 03/04/2024 | Date of signature on the Form 4 filing |
| 06/26/2024 | Expiration date of share tracking awards |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.